Compare VBIO & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VBIO | CISS |
|---|---|---|
| Founded | 2016 | 2022 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.7M |
| IPO Year | 2021 | 2022 |
| Metric | VBIO | CISS |
|---|---|---|
| Price | $2.51 | $0.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 681.5K | 573.6K |
| Earning Date | 11-13-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $780,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.82 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.11 | $0.06 |
| 52 Week High | $4.39 | $6.06 |
| Indicator | VBIO | CISS |
|---|---|---|
| Relative Strength Index (RSI) | 52.64 | 36.58 |
| Support Level | $2.05 | $0.76 |
| Resistance Level | $4.14 | $1.67 |
| Average True Range (ATR) | 0.50 | 0.15 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 26.07 | 1.17 |
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including national and private industrial users, commodity producers, and traders. The company owns and operates a fleet of two dry bulk carriers that transport bulk commodities such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.